Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_provenance.
- NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_assertion description "[Our findings suggest that BCAA supplementation may be useful to suppress liver cancer progression by inhibiting insulin-induced PI3K/Akt and subsequent anti-apoptotic pathway, indicating the importance of BCAA supplementation to the obese patients with advanced liver disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_provenance.
- NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_assertion evidence source_evidence_literature NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_provenance.
- NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_assertion SIO_000772 21769869 NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_provenance.
- NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_assertion wasDerivedFrom befree-20140225 NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_provenance.
- NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_assertion wasGeneratedBy ECO_0000203 NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP317089.RAarSIP8y7Mib_ojfl-_pMPxdx_R_cyyGaZ1HI5o8KkpY130_provenance.